HAL (France)
open access
Persistence of Neutralizing Antibodies and Clinical Protection up to 12 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Elderly
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Respiratory syncytial virus (RSV) in older adults: from infection to outcomes – who gets sick, who gets hospitalized, who survives?#315050
- Long-Term Respiratory Muscle Strength in Young COVID-19 Patients#1073324
- Effects of Aging on Primary and Secondary Vaccine Responses#901109
- Immune responses in aging adults.#281002
- Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia#835385
Record · ID 391814
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive